Tag: AMR
C-CAMP supported by Office of PSA hosts the 2nd India AMR...
The workshop convened over 100 key stakeholders across the national and global AMR innovation ecosystem in the largest such dialogue of its kind in the Asia Pacific
C-CAMP & ICARS announce seven winners of inaugural One Health AMR...
Selected innovations across human, animal, and environmental health aim to curb antimicrobial resistance under India’s National Action Plan on AMR 2.0
C-CAMP–anchored India AMR Innovation Hub announced as the innovation arm of...
Conceived under the leadership of the Office of the Principal Scientific Adviser (PSA) to the Government of India and anchored by C-CAMP, IAIH is a convergent, collaborative platform of key national and international stakeholders towards reducing the AMR burden in India
Indian researchers develop new AI framework to aid discovery of next-generation...
New AI framework mimics real-world chemical synthesis to generate drug candidates that are both novel and lab-ready, offering faster routes to cancer and antibiotic resistance therapies
CIDSCON 2025: Judicious use of antibiotics essential to fight AMR: Experts
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
C-CAMP and UK’s Global AMR Innovation Fund announces new research call
The initiative focuses on delivering contextual solutions for low- and middle-income countries (LMICs) that are globally relevant and scalable
Fighting back against superbugs- A joint initiative by UK and India...
Researchers in the UK and India are collaborating to tackle the urgent issue of antibiotic overprescription by dentists
Cipla becomes first to launch AMR drug ‘ZEMDRI’ in India
Plazomicin is a novel anti-microbial with demonstrated activity against multi-drug resistant (MDR) bacteria and clinical efficacy in complicated Urinary Tract infections (cUTI)
AMR Challenge 2024-25, in collaboration with GAMRIF, announces 9 winners
The C-CAMP national AMR Challenge that was launched in Aug, 2024 received about 200 applications from innovators and startups across India
DBT partners Oxford Nanopore to launch two Genomic Centres of Excellence...
Institutes under the Department of BioTechnology (DBT) sign Letters of Intent with Oxford Nanopore to establish next-generation Genomic Centres of Excellence and new suite of R&D collaborations including in rare disease, newborn screening, oral cancer, and antimicrobial resistance (AMR) studies